Besin Denied Quick Exit In Testosterone Replacement MDL
An Illinois federal judge overseeing multidistrict litigation over heart health risks and injuries allegedly caused by testosterone replacement therapy drugs refused Monday to toss claims against Belgian drug manufacturer Besins Healthcare,...To view the full article, register now.
Already a subscriber? Click here to view full article